Host Fred Goldstein invites Charles Makin, Global HEOR, RWE and Market Access Advisor to discuss their poster at AMCP Nexus 2023 on RWE adoption by US Payers.

Host Fred Goldstein invites Dr. Emmanuel Mensah, a Firm Chief and Faculty at Beth Israel Deaconess Medical Center / Harvard Medical School to discuss taking a look in the mirror and reflect on our own implicit biases and disparities in health care.

Host Fred Goldstein invites Jim Hopsicker, AMCP President & Vice President, Health and Pharmacy Management at MVP Health Care, Inc., and Susan Cantrell, AMCP CEO, to discuss the state of AMCP Priorities.

Host Fred Goldstein invites Adam Colborn, Director, Government Affairs at AMCP to discuss AMCP Federal Legislative Priorities on this second episode of a two part discussion.

Host Fred Goldstein discusses current biologic options and the impact to the Immunology Market landscape with Michael Rothrock MHA, MBA, and Chronis H. Manolis, RPh.

Health care expert Fred Goldstein sits down with Adam Colborn, director of government affairs at AMCP, to discuss AMCP’s federal policy priorities in the 118th Congress.

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! speaks with Dr. Scott Whittle from Meridian Solutions about the pathways to bringing app-based prescription digital therapeutic solutions to health care.

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up!, sits down with Marissa Schlaifer and Billy West, AMCP Distinguished Service Award recipients, to discuss the role of AMCP in their careers.

Host Fred Goldstein invites Ruby Singh, Senior Vice President of Education and Instruction and Brittany Henry, Director of Education Programs, with AMCP, to discuss the brand-new 3rd edition of the AMCP Fundamentals of Managed Care Pharmacy Training Program scheduled for release July 2023.

Don't miss out on your chance to comment! Health care expert Fred Goldstein sits down with Ellen Whipple, BS Pharm, PharmD, to discuss the AMCP Format revision focused on digital therapeutics, health disparities, real-world evidence, PIE Deck guidance, and streamlining dossier development.